This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hunt, S. C. Articles by Williams, R. R. Search for Related Content PubMed PubMed Citation Articles by Hunt, S. C. Articles by Williams, R. R.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:912-917.)
© 1996 American Heart Association, Inc.

Articles

Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees

Steven C. Hunt; Lily L. Wu; Paul N. Hopkins; Roger R. Williams

the Cardiovascular Genetics Research Clinic, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

Correspondence to Steven C. Hunt, PhD, Cardiovascular Genetics, 410 Chipeta Way, Room 161, Salt Lake City, UT 84108. E-mail steve@ucvg.med.utah.edu.

In case-control studies, lower serum bilirubin levels have been associated with increased risk of developing coronary heart disease (CHD). We have also previously shown that serum bilirubin has a significant polygenic component. The purpose of the present investigation was to determine whether there was statistical evidence for a major gene explaining a significant portion of individual variation in serum total bilirubin levels and whether this gene might alter the risk of CHD. Serum bilirubin measurements were obtained from 1240 adults in 84 Utah pedigrees screened twice: from 1980 to 1983 and again from 1983 to 1986. Bivariate maximum-likelihood segregation analysis of serum bilirubin levels obtained from the two clinic visits indicated that a major gene was responsible for elevated levels in 11.5% of the persons in these pedigrees. Phenotypic variations in visit 1 bilirubin arising from polygenes were highly correlated with the phenotypic variation due to polygenes in visit 2 bilirubin, indicating a stable genetic contribution to bilirubin over 2.5 years of follow-up. The major gene explained 27% and 28% of the variance in bilirubin levels at visit 1 and visit 2, respectively. There were no correlations of unmeasured environmental factors influencing bilirubin between the two clinic visits. At both visits, persons with early CHD had lower levels of bilirubin than unaffected persons (P<.01). The odds ratio for the risk of CHD in the high-homozygote group was 0.31, P=.09. We conclude that there is a major gene modestly raising serum bilirubin levels. Since cross-sectional data indicate that low serum bilirubin levels increase the risk of CHD, this major gene may be protective against CHD for about 12% of the persons in this study.

Key Words: coronary heart disease • genetics • risk factor • segregation analysis

This article has been cited by other articles:

				T. Vera, J. P. Granger, and D. E. Stec Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R738 - R743. [Abstract] [Full Text] [PDF]

				H. Gullu, D. Erdogan, D. Tok, S. Topcu, M. Caliskan, T. Ulus, and H. Muderrisoglu High Serum Bilirubin Concentrations Preserve Coronary Flow Reserve and Coronary Microvascular Functions Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2289 - 2294. [Abstract] [Full Text] [PDF]

				T. Morita Heme Oxygenase and Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1786 - 1795. [Abstract] [Full Text] [PDF]

				T. W. Sedlak and S. H. Snyder Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle Pediatrics, June 1, 2004; 113(6): 1776 - 1782. [Full Text] [PDF]

				F. Innocenti, S. D. Undevia, L. Iyer, P. Xian Chen, S. Das, M. Kocherginsky, T. Karrison, L. Janisch, J. Ramirez, C. M. Rudin, et al. Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan J. Clin. Oncol., April 15, 2004; 22(8): 1382 - 1388. [Abstract] [Full Text] [PDF]

				L. Novotny and L. Vitek Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies Experimental Biology and Medicine, May 1, 2003; 228(5): 568 - 571. [Abstract] [Full Text] [PDF]

				M. Mayer Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease Clin. Chem., November 1, 2000; 46(11): 1723 - 1727. [Abstract] [Full Text] [PDF]

				O. Cunningham, A. Dunne, P. Sabido, D. Lightner, and T. J. Mantle Studies on the Specificity of the Tetrapyrrole Substrate for Human Biliverdin-IXalpha Reductase and Biliverdin-IXbeta Reductase. STRUCTURE-ACTIVITY RELATIONSHIPS DEFINE MODELS FOR BOTH ACTIVE SITES J. Biol. Chem., June 16, 2000; 275(25): 19009 - 19017. [Abstract] [Full Text] [PDF]